Skip to main content
SpringerLink
Log in

Reproducibility over time of measurements of androgens, estrogens and hydroxy estrogens in urine samples from post-menopausal women

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Sex steroid concentrations in urine samples from post-menopausal women have been associated with risk of various chronic diseases. The basic requirement for the assessment of risk in such large-scale epidemiological studies is that subjects be ranked accurately by their average, long-term hormone levels. We examined the reproducibility over time of measurements of urinary testosterone (T), 5α-androstane-3α, 17β-diol (ADIOL), estrone (E1), estradiol (E2), 2-hydroxy estrone and 2-hydroxy estradiol, (2(OH)-E), 16α-hydroxyestrone (16α(OH)-E1) and the ratio of 2(OH)-E and 16α(OH)-E1, in a representative sub-sample of post-menopausal women (n = 43) participating in an ongoing prospective cohort study. Women collected three first morning urine voids on different occasions, with average time difference between the first and the third urine sample of 5.1 years. T, ADIOL, E1 and E2 were measured by radio immunoassay after enzymatic hydrolysis, solid-phase extraction and HPLC purification of the samples, while 2(OH)-E and 16α(OH)-E1 were assayed by solid-phase enzyme immunoassay after enzymatic hydrolysis. Intra-class correlation co-efficients (ICCs) over time were very good for T (r = 0.85), acceptable for E2, E1 and ADIOL (r > 0.55), but low for 2(OH)-E, 16α(OH)-E1 and their ratio (r < 0.46). The adjustment for creatinine concentrations did not increase these correlations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Thomas HV, Reeves GK, Key TJ. Endogenous estrogen and postmenopausal breast cancer: A quantitative review. Cancer Causes Control 1997; 8: 922–928.

    Google Scholar 

  2. Secreto G, Toniolo P, Berrino F, et al. Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res 1991; 51: 2572–2576.

    Google Scholar 

  3. Ettinger B, Pressman ASP, Bauer DC, Cauley JA, Cummings SR. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: The study of osteoporotic fractures. 1998 (report).

  4. Garnero P, Sornay-Rendu E, Claustrat B FAU, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. 2000 (report).

  5. Moreira-Andres MN, Canizo FJ, Hawkins F. Is there a place for urinary growth hormone measurement? Acta Endocrinol (Copenh) 1993; 128: 197–201.

    Google Scholar 

  6. Brook CG, Jacobs HS, Stanhope R, Adams J, Hindmarsh P. Pulsatility of reproductive hormones: Applications to the understanding of puberty and to the treatment of infertility. Baillieres Clin Endocrinol Metab 1987; 1: 23–41.

    Google Scholar 

  7. Ikegawa S, Lahita R, Fishman J. Concentration of 16 alpha-hydroxyestrone in human plasma as measured by a specific RIA. J Steroid Biochem 1983; 18: 329–332.

    Google Scholar 

  8. Falk RT, Rossi SC, Fears TR, et al. A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: Reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid. Cancer Epidemiol Biomarkers Prev 2000; 9: 81–87.

    Google Scholar 

  9. Armstrong BK, White E, Saracci R. Principles of Exposure Measurement in Epidemiology. Oxford University Press, New York, 1992.

    Google Scholar 

  10. Cauley JA, Gutai JP, Kuller LH, Powell JG. Reliability and interrelations among serum sex hormones in postmenopausal women. Am J Epidemiol 1991; 133: 50–57.

    Google Scholar 

  11. Toniolo P, Koenig KL, Pasternack BS, et al. Reliability of measurements of total, protein-bound, and unbound estradiol in serum. Cancer Epidemiol Biomarkers Prev 1994; 3: 47–50.

    Google Scholar 

  12. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995; 4: 649–654.

    Google Scholar 

  13. Muti P, Trevisan M, Micheli A, et al. Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 1996; 5: 917–922.

    Google Scholar 

  14. Michaud DS, Manson JE, Spiegelman D, et al. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 1999; 8: 1059–1064.

    Google Scholar 

  15. Micheli A, Muti P, Pisani P, et al. Repeated serum and urinary androgen measurements in premenopausal and postmenopausal women. J Clin Epidemiol 1991; 44: 1055–1061.

    Google Scholar 

  16. de Waard F, Collette HJ, Rombach JJ, Baanders-van Halewijn EA, Honing C. The DOM project for the early detection of breast cancer, Utrecht, The Netherlands. J Chronic Dis 1984; 37: 1–44.

    Google Scholar 

  17. Venturelli E, Manzari A, Cavalleri A, Benzo M, Secreto G, Marubini E. Urinary testosterone measurement by gas chromatography after solid-phase extraction and high-performance liquid chromatography. J Chromatogr 1992; 582: 7–12.

    Google Scholar 

  18. Minut GJ, Cambie M, Lanzoni M, Marubini E, Secreto G. Urinary 5 alpha-androstanediol and 5 betaandrostanediol measurement by gas chromatography after solid-phase extraction and high-performance liquid chromatography. Int J Biol Markers 1999; 14: 154–159.

    Google Scholar 

  19. Falk RT, Gail MH, Fears TR, et al. Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in pre-and postmenopausal women. Cancer Epidemiol Biomarkers Prev 1999; 8: 567–577.

    Google Scholar 

  20. Key TJ, Wang DY, Brown JB, et al. A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer 1996; 73: 1615–1619.

    Google Scholar 

  21. Vermeulen A. Sex hormone status of the postmenopausal woman. Maturitas 1980; 2: 81–89.

    Google Scholar 

  22. Bolelli G, Muti P, Micheli A, et al. Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev 1995; 4: 509–513.

    Google Scholar 

  23. Kley HK, Schlaghecke R, Kruskemper HL. Stability of steroids in plasma over a 10-year period. J Clin Chem Clin Biochem 1985; 23: 875–878.

    Google Scholar 

  24. Meilahn EN, De Stavola B, Allen DS, et al. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br J Cancer 1998; 78: 1250–1255.

    Google Scholar 

  25. Ursin G, London S, Stanczyk FZ, et al. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1999; 91: 1067–1072.

    Google Scholar 

  26. Ziegler RG, Rossi SC, Fears TR, et al. Quantifying estrogen metabolism: An evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine. Environ Health Perspect 1997; 105(Suppl 3): 607–614.

    Google Scholar 

  27. Chen C, Malone KE, Prunty J, Daling JR. Measurement of urinary estrogen metabolites using a monoclonal enzyme-linked immunoassay kit: Assay performance and feasibility for epidemiological studies. Cancer Epidemiol Biomarkers Prev 1996; 5: 727–732.

    Google Scholar 

  28. Michnovicz JJ, Adlercreutz H, Bradlow HL. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J Natl Cancer Inst 1997; 89: 718–723.

    Google Scholar 

  29. Fowke JH, Longcope C, Hebert JR. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev 2000; 9: 773–779.

    Google Scholar 

  30. Michnovicz JJ, Naganuma H, Hershcopf RJ, Bradlow HL, Fishman J. Increased urinary catechol estrogen excretion in female smokers. Steroids 1988; 52: 69–83.

    Google Scholar 

  31. Muti P, Deutsch A, Freudenheim J, Bolelli G, Hill L, Trevisan M. Why and how to measure urinary sex steroid metabolites in epidemiological studies in women. Nutr Metab Cardiovasc Dis 2000; 10: 85–91.

    Google Scholar 

  32. Gorgels WJ, Graaf Y, Blankenstein MA, Collette HJ, Erkelens DW, Banga JD. Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: A nested case-referent study in the DOMcohort. J Clin Epidemiol 1997; 50: 275–281.

    Google Scholar 

  33. Zheng W, Dai Q, Custer LJ, et al. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1999; 8: 35–40.

    Google Scholar 

  34. Zacur H, Kaufman SC, Smith B, et al. Does creatinine adjustment of urinary pregnanediol glucuronide reduce or introduce measurement error? Gynecol Endocrinol 1997; 11: 29–33.

    Google Scholar 

  35. Boeniger MF, Lowry LK, Rosenberg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: A review. Am Ind Hyg Assoc J 1993; 54: 615–627.

    Google Scholar 

  36. Alessio L, Berlin A, Dell'Orto A, Toffoletto F, Ghezzi I. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Health 1985; 55: 99–106.

    Google Scholar 

  37. Walser M. Creatinine excretion as a measure of protein nutrition in adults of varying age. JPEN J Parenter. Enteral Nutr 1987; 11: 73S–78S.

    Google Scholar 

  38. Welle S, Thornton C, Totterman S, Forbes G. Utility of creatinine excretion in body-composition studies of healthy men and women older than 60 y. Am J Clin Nutr 1996; 63: 151–156.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hormones and Cancer Group, International Agency for Research on Cancer, 69372, Lyon, France

    S. Rinaldi, R. Kaaks & C. Biessy

  2. Julius Center for General Practice and Patient Oriented Research, University Medical Center, 3508 GA, Utrecht, The Netherlands

    C.N. Moret, P.H.M. Peeters & P.A.H. van Noord

  3. Department of Food Science and Nutrition, University of Minnesota, St. Paul, 55108, Minnesota, USA

    M.S. Kurzer

  4. Service de Radioanalyse et Radiopharmacie, Centre de Médecine Nucleaire, Hôpital Neurocardiologique, 69003, Lyon, France

    H. Déchaud

Authors
  1. S. Rinaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C.N. Moret
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Kaaks
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Biessy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M.S. Kurzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Déchaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P.H.M. Peeters
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P.A.H. van Noord
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rinaldi, S., Moret, C., Kaaks, R. et al. Reproducibility over time of measurements of androgens, estrogens and hydroxy estrogens in urine samples from post-menopausal women. Eur J Epidemiol 18, 417–424 (2003). https://doi.org/10.1023/A:1024209122412

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024209122412

Search

Navigation